Today in Seminole County, Florida, a new technology named ‘Drug Alert AI’ was introduced to help address the drug crisis by ...
Pharmaceutical Technology on MSN
Debiopharm and NetTargets to identify synergistic drug combos for ADCs
NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.
Republican senators introduce bills targeting nitazenes, synthetic opioids potentially deadlier than fentanyl. New ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...
Men and women react differently to different drugs. That may sound like a no-brainer, but for years researchers have mainly focused on male patients’ reactions to drugs in clinical trials, which has ...
SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign ...
The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...
News-Medical.Net on MSN
Harnessing bioinformatics to fast-track the discovery of spinal cord injury drug
Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...
GlobalData on MSN
MapLight’s $251m IPO sees schizophrenia drug developers on top
Illuminating its plans, neurological disease specialist MapLight said it would offer 14,750,000 shares of its common stock at $17.00 per share, which works out to an IPO of around $251m. The biotech ...
The Centers for Medicare & Medicaid Services (CMS), the Office of the National Coordinator for Health Information Technology (ONC), and thr Department of Health and Human Services (HHS) published 89 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results